Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model von Muqbil, Irfana, Chaker, Mahmoud, Aboukameel, Amro, Mohammad, Ramzi M., Azmi, Asfar S., Ramchandren, Radhakrishanan

Volltext

Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study von Seymour, Erlene K, Khan, Husain Yar, Li, Yiwei, Chaker, Mahmoud, Muqbil, Irfana, Aboukameel, Amro, Ramchandren, Radhakrishanan, Houde, Christiane, Sterbis, Golbon, Yang, Jay, Bhutani, Divaya, Pregja, Silvana, Reichel, Kathy, Huddlestun, Amy, Neveux, Colleen, Corona, Kelly, Landesman, Yosef, Shah, Jatin, Kauffman, Michael, Shacham, Sharon, Mohammad, Ramzi M, Azmi, Asfar S, Zonder, Jeffrey A

Volltext

Selinexor in combination with R-CHOP for frontline treatment of non-Hodgkin lymphoma: results of a phase 1 study von Seymour, Erlene K., Yar Khan, Husain, li, Yiwei, Chaker, Mahmoud, Muqbil, Irfana, Aboukameel, Amro, Ramchandren, Radhakrishanan, Houde, Christiane, Sterbis, Golbon, Yang, Jay, Bhutani, Divaya, Pregja, Silvana, Reichel, Kathy, Huddlestun, Amy, Neveux, Colleen, Corona, Kelly, Landsman, Yosef, Shah, Jatin, Kauffman, Michael, Shacham, Sharon, Mohammad, Ramzi M., Azmi, Asfar S., Zonder, Jeffrey A.

Volltext